| Ms Karissa Lynn Schwartz, MA, CCC-SLP | |
|
Providence Portland Medical Center, 4805 Ne Glisan St, Portland, OR 97213 | |
| (503) 215-1111 | |
| Not Available |
| Full Name | Ms Karissa Lynn Schwartz |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Providence Portland Medical Center, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023507795 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 15006 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Karissa Lynn Schwartz, MA, CCC-SLP Po Box 6722, Portland, OR 97228-6722 Ph: (971) 244-3757 | Ms Karissa Lynn Schwartz, MA, CCC-SLP Providence Portland Medical Center, 4805 Ne Glisan St, Portland, OR 97213 Ph: (503) 215-1111 |
News Archive
A new study has shown that products made of fermented soy such as miso and soy sauce can help individuals live longer. The study titled, "Association of soy and fermented soy product intake with total and cause specific mortality: prospective cohort study," was published in the latest issue of the journal British Medical Journal.
Researchers from the Department of Neurology at NYU Langone Medical Center identified potential benefits of a new computer application that automatically detects subtle brain lesions in MRI scans in patients with epilepsy. In a study published in the February 2011 issue of PLoS ONE, the authors discuss the software's potential to assist radiologists in better identifying and locating visually undetectable, operable lesions.
The immunosuppressive drug fingolimod (trade name: Gilenya-) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.
Since its inception in July 2009, the Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, at the Institute of Medicine has worked to develop a blueprint for using nurse-led models of innovation to improve the health care system.
› Verified 6 days ago
Mira E Shah, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2855 Se 61st Avenue, Portland, OR 97206 Phone: 503-348-0931 | |
Hearing & Speech Institute Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1675 Sw Marlow Ave, Suite 200, Portland, OR 97225 Phone: 503-228-6479 Fax: 503-228-4248 | |
Dr. Philip J Levinson, PH.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1507 Sw Morrison St, Suite A, Portland, OR 97205 Phone: 503-226-1048 Fax: 503-226-1049 | |
Katherine Rhodes, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 730 Ne 148th Ave, Portland, OR 97230 Phone: 503-262-9359 | |
Ms. Brenda Joy Nuckton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 0270 Sw Palatine Hill Rd, Portland, OR 97219 Phone: 503-236-4940 | |
Ms. Lauren Renee Zlott, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2711 Se 28th Ave, Portland, OR 97202 Phone: 530-921-2151 Fax: 971-206-5203 | |
Kelly Wonitowy, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1406 Se 85th Ave, Portland, OR 97216 Phone: 971-227-0523 |